However, whether these estradiol-repressible miRNAs coordinately control cell proliferation and survival by targeting bcl-2, cyclin D1 and survivin at the post-transcriptional level in breast cancer cells is not fully investigated. This evidence concerns the gene BIRC5 and breast carcinoma.